NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Dollar Gains Against Major Currencies as Fed Leaves Interest Rates Unchanged

The US dollar strengthened against major currencies on Wednesday, following the US Federal Reserve's decision to leave interest rates unchanged. This move has left investors on edge, as the situation in the US-Israel war with Iran shows little sign of easing.

The Federal Reserve's 8-4 vote marked its most divided decision since 1992, highlighting the challenges that incoming Fed Chair Kevin Warsh will face in pushing for rate cuts. Current Chair Jerome Powell's term is set to end on May 15.

The impact of the Fed's decision was evident in currency markets, with the euro slipping 0.29% to $1.1679 and sterling falling 0.31% to $1.34765.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Investor Takeaway

Investors should be cautious of potential market volatility due to geopolitical tensions.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.